Found "AI": 1,172 results
Sort by
Sort by
Last updated
Thailand's AMR Strategy: Insights from the 5th National Forum on AMR
Thailand's National Forum on Antimicrobial Resistance (AMR), held every two years, serves as a platform to share knowledge and reinforce the importance of AMR as a global public health threat. Yet AMR rarely commands public attention, compared to non-communicable diseases, despite being associated w
Introduction of early health technology assessment for innovators, clinicians, and funders
Abstract
Health technology faces rising costs, system complexities, and gaps between development and coverage policies, limiting translation into practice. Traditional health technology assessment (HTA) evaluates technologies at late stages, providing little support if a technology fails to secur
Enhancing Financial Sustainability and Efficiency in Thailand\\\'s Universal Health Coverage Program: A Research Initiative
69145002RU002L0Financial Sustainability,Thailand,Universal Health Coverage
Co-creating a process for integrating regulatory approval of late- stage clinical research into the Thailand’s Universal Benefit Package through Action Research
The research and development of new medicines is a lengthy and sequential process that spans more than a decade, culminating in regulatory approval based on evidence of quality, safety, and efficacy from clinical trial data. In Thailand, it takes nearly an additional decade for new medicines to be included in the Thailand National List of Essential
Can AI Really Help Us Prevent Diabetes and Hypertension in Thailand?
Non-communicable diseases (NCDs) are often called “silent killers”, but there is nothing silent about their impact. They remain one of the hardest public health battles to win. According to the World Health Organisation (WHO), they cause 43 million deaths worldwide and account for 75% of non-pandemi
From Potential to Practice: AI for Diabetes and Hypertension Prevention in Thailand
Background & RationaleNon-communicable diseases (NCDs) are the leading cause of death worldwide, responsible for 43 million deaths annually and accounting for 75% of all non-pandemic-related mortality globally [1]. Cardiovascular disease, diabetes, cancer, and chronic respiratory conditions drive this burden, yet most health systems remain orie
Target product profiles: opportunities and implications for health innovation development–a scoping review
Highlights
By reviewing 120 Target Product Profiles (TPPs), this study identified key aspects of TPP development processes, stakeholder involvement, common themes, major limitations, and priorities for follow-up research.
Health technologies were classified into five categories, and the pr
Combating a Global Public Health Threat: Antimicrobial Resistance – What are we doing?
Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le
10 / Page